1.Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma.
Yoon Jin CHA ; Woo Hee JUNG ; Nam Hoon CHO ; Ja Seung KOO
Yonsei Medical Journal 2015;56(3):598-607
PURPOSE: The aims of this study were to compare the expression of sarcosine metabolism-related proteins between invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) and to determine the implications of these results. MATERIALS AND METHODS: Tissue microarrays were constructed, containing 30 samples from normal breast tissue, 114 samples from patients with ILC, and 692 samples from patients with IDC. Immunohistochemical staining was performed to examine the expression of sarcosine metabolism-related proteins [glycine N-methyltransferase, sarcosine dehydrogenase, and l-pipecolic acid oxidase (PIPOX)]. RESULTS: The sarcosine metabolic phenotype differed between ILC and IDC (p<0.001). In IDC, sarcosine metabolic phenotype was distributed as null type (61.7%)>low sarcosine type (30.4%)>high sarcosine type (5.0%)>intermediate type (2.9%). However, in ILC, the sarcosine metabolic phenotype was distributed as low sarcosine type (61.4%)>null type (32.5%)>intermediate type (5.3%)>high sarcosine type (0.9%). PIPOX showed higher expression in ILC than in IDC (p<0.001) and correlated with androgen receptor (AR) positivity (p=0.001) in ILC. CONCLUSION: Expression of sarcosine metabolism-related proteins differed between ILC and IDC. Low sarcosine type was the majority sarcosine metabolic phenotype of ILC. PIPOX expression was predominant in ILC and correlated with AR positivity.
Adult
;
Breast/pathology
;
Breast Neoplasms/*metabolism/pathology
;
Carcinoma, Ductal, Breast/*metabolism/pathology
;
Carcinoma, Lobular/*metabolism
;
Female
;
Humans
;
Immunohistochemistry
;
Middle Aged
;
Multivariate Analysis
;
Phenotype
;
Proportional Hazards Models
;
Regression Analysis
;
Retrospective Studies
;
Sarcosine/genetics/*metabolism
;
Tissue Array Analysis
2.Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy.
Kazuo FUSHIMI ; Charles LONG ; Neha JAYARAM ; Xiaoping CHEN ; Liming LI ; Jane Y WU
Protein & Cell 2011;2(2):141-149
Mutations in the fused in sarcoma/translocated in liposarcoma (FUS/TLS) gene have been associated with amyotrophic lateral sclerosis (ALS). FUS-positive neuropathology is reported in a range of neurodegenerative diseases, including ALS and fronto-temporal lobar degeneration with ubiquitin-positive pathology (FTLDU). To examine protein aggregation and cytotoxicity, we expressed human FUS protein in yeast. Expression of either wild type or ALS-associated R524S or P525L mutant FUS in yeast cells led to formation of aggregates and cytotoxicity, with the two ALS mutants showing increased cytotoxicity. Therefore, yeast cells expressing human FUS protein recapitulate key features of FUS-positive neurodegenerative diseases. Interestingly, a significant fraction of FUS expressing yeast cells stained by propidium iodide were without detectable protein aggregates, suggesting that membrane impairment and cellular damage caused by FUS expression may occur before protein aggregates become microscopically detectable and that aggregate formation might protect cells from FUS-mediated cytotoxicity. The N-terminus of FUS, containing the QGSY and G rich regions, is sufficient for the formation of aggregates but not cytotoxicity. The C-terminal domain, which contains a cluster of mutations, did not show aggregation or cytotoxicity. Similar to TDP-43 when expressed in yeast, FUS protein has the intrinsic property of forming aggregates in the absence of other human proteins. On the other hand, the aggregates formed by FUS are thioflavin T-positive and resistant to 0.5% sarkosyl, unlike TDP-43 when expressed in yeast cells. Furthermore, TDP-43 and FUS display distinct domain requirements in aggregate formation and cytotoxicity.
Amino Acid Sequence
;
Amino Acid Substitution
;
DNA-Binding Proteins
;
genetics
;
metabolism
;
Humans
;
Mutation
;
Neurodegenerative Diseases
;
pathology
;
Protein Structure, Tertiary
;
RNA-Binding Protein FUS
;
chemistry
;
genetics
;
metabolism
;
Recombinant Proteins
;
genetics
;
metabolism
;
toxicity
;
Saccharomyces cerevisiae
;
growth & development
;
metabolism
;
Sarcosine
;
analogs & derivatives
;
pharmacology
;
Thiazoles
;
metabolism